北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel.:010-50867666 传真/Fax:010-56916450 网址/Website:www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 北京市康达律师事务所 关于广东冠豪高新技术股份有限公司 2025 年第三次临时股东大会的 法律意见书 二〇二五年九月 法律意见书 北京市康达律师事务所 关于广东冠豪高新技术股份有限公司 2025 年第三次临时股东大会的法律意见书 康达股会字【2025】第 0370 号 致：广东冠豪高新技术股份有限公司 北京市康达律师事务所（以下称"本所"）接受广东冠豪高新技术股份有限公司（以 下称"公司"）的委托，指派本所律师列席了公司于 2025 年 9 月 9 日召开 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600433 证券简称：冠豪高新 公告编号：2025-036 广东冠豪高新技术股份有限公司 2025年第三次临时股东大会决议公告 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 9 月 9 日 (二)股东大会召开的地点：广东省广州市海珠区海洲路 18 号 TCL 大厦 26 层公司 会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 316 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 827,895,762 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 47.3008 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，由公司董事长李飞先生主持。大会采取现 场投票与网络投票相结合的表决方式，符合《 ...

Group 1 - The major shareholder, Guangdong Yuecai Venture Capital Co., Ltd. (粤创投), holds 77,595,101 shares, accounting for 4.43% of the total share capital of Guangdong Guanhao High-tech Co., Ltd. (冠豪高新) [2] - The reduction plan involves a maximum reduction of 17,502,792 shares, which is not more than 1% of the total shares, within three months after the announcement [2] - The reduction will be executed through centralized bidding, and the price will be determined based on market conditions at the time of the sale [2][4] Group 2 - The major shareholders have previously committed to not trading their shares for 36 months following the stock reform in 2006, with a minimum sale price of RMB 4.5 per share [5] - The current reduction plan is consistent with the previously disclosed commitments made by the major shareholders [6] - The company will ensure compliance with relevant regulations during the reduction process and will fulfill its disclosure obligations [7]

证券代码：600433 证券简称：冠豪高新 公告编号：2025-035 广东冠豪高新技术股份有限公司 关于持股 5%以上股东减持股份计划公告 | | 持股数量 | | | | | 一致行动关系形成原 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名称 | | | 持股比例 | | | | | | | | （股） | | | | 因 | | | | | 广东粤财创业投 | | | | | | | | | | 资有限公司 | | | | | | | | | | 广州润华置业有 | | | | | | | | | | 第一组 限公司 | | | | | | | | | | 广东粤财实业发 | | | | | | | | | | 展有限公司 | | | | | | | | | | 合计 | 103,354,541 5.91% | | | — | | | | | | 二、减持计划的主要内容 | | | | | | | | | | 股东名称 | 广东粤财创业投资有限公司 | | | | | | | | | 计划减持数量 | 不超过：17 ...

证券日报网讯9月5日晚间，冠豪高新（600433）发布公告称，股东粤创投计划自本公告披露之日起15个 交易日后的3个月内通过集中竞价交易方式减持公司股份不超过17，502，792股，即减持数量不超过公 司股份总数的1%，且任意连续90个自然日内通过集中竞价交易方式减持的股份总数不超过公司股份总 数的1%。 ...

Summary of Key Points Core Viewpoint - On September 5, Guizhou Moutai disclosed its shareholding increase, while 24 listed companies announced shareholding reductions, indicating a mixed sentiment in the market regarding stock performance and investor confidence [1][2]. Group 1: Shareholding Increases - Guizhou Moutai's controlling shareholder, Moutai Group, received a commitment letter for a loan of up to 2.7 billion yuan from Agricultural Bank [2]. Group 2: Shareholding Reductions - A total of 24 companies reported shareholding reductions, including: - Aohai Technology: Shareholder plans to reduce holdings by up to 7 million shares [2]. - Ruihu Mould: Shareholder plans to reduce up to 3% of company shares [2]. - Guanghua Technology: Some executives plan to reduce a total of up to 477.81 thousand shares [2]. - Kaipu Detection: Vice President plans to reduce company shares [2]. - Liren Technology: Controlling shareholder plans to reduce up to 3% of shares [2]. - Tonghuashun: Controlling shareholder plans to reduce a total of up to 0.26% of shares [2]. - Kexin Innovation Source: One of the actual controllers plans to reduce up to 141.5 thousand shares [2]. - Other companies such as Feima International, Changjiang Materials, and others also reported various plans for share reductions [2].

Group 1 - Baoti shares: The controlling shareholder has increased its stake by 1.004% [1] - Chengda Pharmaceutical: Qianhai Shengtai plans to reduce its holdings by 7.27% [1] - Huawu Co., Ltd.: Nie Jinghua and others plan to reduce their holdings by no more than 3% within three months [1] Group 2 - Changjiang Materials: The controlling shareholder plans to reduce its holdings by no more than 3% [1] - Weishi Electronics: The controlling shareholder's reduction plan does not exceed 3% [1] - Jialian Technology: A related party plans to reduce its holdings by 2.6166% within three months [1] Group 3 - Funeng Technology: Shareholders plan to reduce their holdings by no more than 2% [1] - Lanfeng Biochemical: Hainan Wenqin reduced its holdings by 2.00% [1] - Koweil: Shareholders Jingkun Investment and Hetu Investment plan to reduce their holdings by no more than 2.34% [1] Group 4 - Huayin Power: Hunan Energy plans to reduce its holdings by 1% [1] - Bid Pharmaceutical: Zhoushan Xinxin plans to reduce its holdings by 1.00% [1] - Guanhao High-tech: Shareholder Yuechuang Investment plans to reduce its holdings by no more than 1% [1] Group 5 - Juxin Technology: Zhuhai Chenyour plans to reduce its holdings by no more than 0.5% [1] - Tianji Shares: Shantou Tianji reduced its holdings by 0.61% [1]

Group 1 - Huaneng Power announced that its shareholder Hunan Energy Group plans to reduce its stake by up to 20.31 million shares, not exceeding 1% of the total share capital [1] - Ankai Bus reported a production of 1,012 buses in August, a year-on-year increase of 68.06%, with sales of 773 buses, up 46.95% year-on-year [1] - Lianhuan Pharmaceutical received a drug registration certificate for Famotidine injection, classified as a Class 3 chemical drug [1][2] Group 2 - Dongrui Co. reported sales of 94,800 pigs in August, generating revenue of 160 million yuan, a month-on-month decrease of 5.48% [3] - Tiancheng Control's subsidiary received a notification for a passenger car seat assembly project, expected to start production in April 2026 [5] - ST Huluwa obtained a drug registration certificate for Cefodizime capsules, a third-generation broad-spectrum cephalosporin [6] Group 3 - Jiulong Biotech announced the resignation of its Vice Chairman and General Manager Liang Hongjun due to work adjustments [8] - Guanhua High-tech's shareholder plans to reduce its stake by up to 17.50 million shares, not exceeding 1% of the total share capital [9] - Hebei Steel received approval to issue bonds totaling up to 10 billion yuan [10] Group 4 - Yunnan Energy Investment's subsidiaries received a total of 309 million yuan in renewable energy price subsidies [12] - Zhenghong Technology reported sales of 16,800 pigs in August, with a revenue of 22.87 million yuan, showing a year-on-year increase in sales volume of 63.31% [14] - Jilin Aodong's subsidiary received a drug registration certificate for a solution used in asthma treatment [16] Group 5 - Aonong Biological reported a 26.84% year-on-year increase in pig sales volume in August, reaching 150,100 pigs [18] - Xingdesheng announced a share repurchase plan with a budget of 15 to 30 million yuan [20] - Yueyang Lin Paper's Chairman Ye Meng resigned due to work adjustments [22] Group 6 - Kangchen Pharmaceutical's controlling shareholder plans to reduce its stake by up to 4.78 million shares, not exceeding 3% of the total share capital [23] - Changchun Yidong's General Manager Liu Xiaodong resigned due to work adjustments [25] - Zhongzai Resources' subsidiary received a government subsidy of 12.75 million yuan [26] Group 7 - Tianyu Biological reported a 41.89% month-on-month increase in sales revenue from pig sales in August [27] - Changfei Optical's shareholder Draka Comteq B.V. reduced its stake from 10% to 5% [27] - Zhongchuan Technology's Chairman Wu Xingwang resigned due to work adjustments [28] Group 8 - Huakang Clean announced a successful bid for a medical service construction project valued at 131 million yuan [29] - Yuegui Co. plans to establish a wholly-owned subsidiary with a registered capital of 100 million yuan [31] - Baisheng Intelligent's Vice General Manager and Board Secretary Huang Lijun resigned for personal reasons [32] Group 9 - Jiangsu Shuntian will change its stock name to "Suhao Fashion" starting September 10, 2025 [34] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.3759 million shares, not exceeding 1% of the total share capital [35] - Heng Rui Pharmaceutical received approval for clinical trials of HRS-4729 injection [37] Group 10 - Changfei Optical's shareholder plans to reduce its stake by up to 110,000 shares, not exceeding 0.15% of the total share capital [39] - Yutong Bus reported sales of 4,260 vehicles in August, a year-on-year increase of 16.78% [40] - JinkoSolar received 646 million yuan in renewable energy subsidies in August, a 248% increase year-on-year [41] Group 11 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang Technology for AI collaboration [43] - Gongdong Medical's controlling shareholder plans to reduce its stake by up to 3% [44] - Zhonghuan Hailu terminated its control change plan and resumed trading [46] Group 12 - Longzi Co. reported a tax payment of 22.27 million yuan due to a tax audit [48] - Guoguang Chain's controlling shareholder plans to reduce its stake by up to 2.99% [49] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [50] Group 13 - GF Securities reported a cumulative increase in borrowings exceeding 20% of its net assets [51] - China Construction Bank's subsidiary plans to increase capital by 3 billion yuan [52] - Jifeng Technology plans to establish a wholly-owned subsidiary with a capital of 50 million yuan [53] Group 14 - Jiantou Energy received approval for a stock issuance plan to specific investors [54] - Shanghai Laishi's executives plan to collectively increase their holdings by at least 6 million yuan [55] - Wencan Co. reported a fire incident at its subsidiary, with no casualties reported [56]

Group 1 - The core point of the announcement is that Guangdong Guanhao High-tech Co., Ltd. plans to reduce its shareholding by approximately 17.5 million shares, which is no more than 1% of the total shares, to optimize state-owned capital layout and focus on its main business [1] - Guangdong Yuecai Venture Capital Co., Ltd. currently holds about 77.6 million shares, accounting for 4.43% of the total share capital, while its concerted actions with Guangzhou Runhua Real Estate Co., Ltd. and Guangdong Yuecai Industrial Development Co., Ltd. hold approximately 103 million shares, representing 5.91% of the total [1] - The reduction will take place within three months after the announcement, starting 15 trading days from the date of disclosure, and the selling price will be determined based on market conditions at the time of the sale [1] Group 2 - For the fiscal year 2024, Guanhao High-tech's revenue composition is as follows: special paper accounts for 75.7%, special materials 18.51%, color printing products 3.79%, and other businesses 2.01% [2] - As of the latest report, Guanhao High-tech has a market capitalization of 5.4 billion yuan [2]

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 广东冠豪高新技术股份有限公司 关于持股 5%以上股东减持股份计划公告 证券代码：600433 证券简称：冠豪高新 公告编号：2025-035 重要内容提示： 1 大股东持股的基本情况：截至本公告披露之日，广东冠豪高新技术股 份有限公司（以下简称"冠豪高新"或"公司"）股东广东粤财创业投资有 限公司（以下简称"粤创投"）持有公司无限售条件流通股 77,595,101 股，占公司总股本的 4.43%。粤创投及其一致行动人广州润华置业有限 公司、广东粤财实业发展有限公司共持有公司股票无限售条件流通股 103,354,541 股，约占公司总股本的 5.91%。 减持计划的主要内容：公司于近日收到粤创投出具的《股份减持计划 告知函》，为优化国有资本布局，聚焦主业和自身自营，粤创投计划自 本公告披露之日起 15 个交易日后的 3 个月内通过集中竞价交易方式减 持公司股份不超过 17,502,792 股，即减持数量不超过公司股份总数的 1%，且任意连续 90 个自然日内通过集中竞价交 ...